1718 related articles for article (PubMed ID: 28956763)
1. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
2. Estradiol Enhances Antiviral CD4
Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4
Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L
J Virol; 2019 May; 93(9):. PubMed ID: 30787156
[TBL] [Abstract][Full Text] [Related]
4. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
5. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
Çuburu N; Wang K; Goodman KN; Pang YY; Thompson CD; Lowy DR; Cohen JI; Schiller JT
J Virol; 2015 Jan; 89(1):83-96. PubMed ID: 25320297
[TBL] [Abstract][Full Text] [Related]
6. Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.
Sato A; Suwanto A; Okabe M; Sato S; Nochi T; Imai T; Koyanagi N; Kunisawa J; Kawaguchi Y; Kiyono H
J Virol; 2014 Dec; 88(23):13699-708. PubMed ID: 25231301
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
[TBL] [Abstract][Full Text] [Related]
8. Pathological effect of IL-17A-producing TCRγδ(+) T cells in mouse genital mucosa against HSV-2 infection.
Kim JO; Cha HR; Kim ED; Kweon MN
Immunol Lett; 2012 Sep; 147(1-2):34-40. PubMed ID: 22698680
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
Harandi AM; Svennerholm B; Holmgren J; Eriksson K
J Gen Virol; 2001 Apr; 82(Pt 4):845-853. PubMed ID: 11257190
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4
Quadiri A; Prakash S; Dhanushkodi NR; Singer M; Zayou L; Shaik AM; Sun M; Suzer B; Lau LSL; Chilukurri A; Vahed H; Schaefer H; BenMohamed L
J Virol; 2024 May; 98(5):e0159623. PubMed ID: 38587378
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.
Stanfield BA; Rider PJF; Caskey J; Del Piero F; Kousoulas KG
Vaccine; 2018 May; 36(20):2842-2849. PubMed ID: 29655629
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
14. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
Elife; 2021 May; 10():. PubMed ID: 34047696
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
Tang VA; Rosenthal KL
J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
Svensson A; Nordström I; Sun JB; Eriksson K
J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
[TBL] [Abstract][Full Text] [Related]
17. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
18. Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway.
Anipindi VC; Bagri P; Roth K; Dizzell SE; Nguyen PV; Shaler CR; Chu DK; Jiménez-Saiz R; Liang H; Swift S; Nazli A; Kafka JK; Bramson J; Xing Z; Jordana M; Wan Y; Snider DP; Stampfli MR; Kaushic C
PLoS Pathog; 2016 May; 12(5):e1005589. PubMed ID: 27148737
[TBL] [Abstract][Full Text] [Related]
19. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]